Latest share price

Current

703.00p

Average

+18.20p LSE

+2.66% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

26/03/2019

Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel),...

Read more

14/03/2019

Oxford Biomedica plc preliminary results for the year ended 31 December 2018

Read more

12/03/2019

Oxford Biomedica announces R&D collaboration with Microsoft to improve gene...

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo